'Unique Oncology Platform': Gilead (GILD) Earns Two Upgrades After Beat-and-raise Quarter

Go back to 'Unique Oncology Platform': Gilead (GILD) Earns Two Upgrades After Beat-and-raise Quarter
Gilead Sciences (NASDAQ: GILD) Delayed: 151.00 +0.01 (0.01%)
Previous Close $150.99    52 Week High $108.63 
Open $151.00    52 Week Low $71.39 
Day High $151.00    P/E 83.43 
Day Low $151.00    EPS $1.81 
Volume 26,291